GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space
- 1 December 2016
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (23) , 5603-5612
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81325020)
- Personalized Medicines—Molecular Signature-based Drug Discovery and Development
- Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12040311)
This publication has 48 references indexed in Scilit:
- A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1PLOS ONE, 2013
- DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic β-Cells Dysfunction in db/db MicePLOS ONE, 2013
- Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF ratsBMC Pharmacology and Toxicology, 2013
- Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 DiabetesACS Medicinal Chemistry Letters, 2013
- Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 ReceptorMolecular Pharmacology, 2012
- A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in RodentsPLOS ONE, 2012
- Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2012
- AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in RodentsPLOS ONE, 2011
- Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonistsBioorganic & Medicinal Chemistry Letters, 2009
- Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in MiceDiabetes, 2008